Sample-Specific Generalized Cross-Validation for Gene Network Analysis of Cytarabine Response in Cancer Cell Lines
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27188261 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Jooee Oh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics, Sungshin Women's University, Seoul 02844, Republic of Korea. Hauptthemen laut MEDLINE: Gene Regulatory Networks, Cytarabine, Neoplasms, Antimetabolites, Antineoplastic. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Sample-specific gene regulatory network analysis can reveal molecular heterogeneity associated with individual characteristics, such as anticancer drug sensitivity. The varying coefficient model with kernel-based L1 regularization enables the estimation of such networks, but its performance depends strongly on hyperparameter selection. Conventional cross-validation is computationally intensive and provides only an averaged evaluation across samples, limiting its suitability for sample-specific analysis. To address these limitations, we propose doubleS-GCV, a sample-specific generalized cross-validation criterion for selecting hyperparameters in sample-specific gene network estimation. DoubleS-GCV provides a separate model evaluation for each sample while substantially reducing computational burden. Monte Carlo simulations demonstrated that doubleS-GCV achieved accurate gene selection and network estimation and outperformed conventional information criteria, including AIC, BIC, AICC, and HQC. Application to GDSC cancer cell lines identified Cytarabine sensitivity-specific gene networks and candidate biomarkers supported by previous studies. The estimated networks also exhibited nonlinear structural changes across Cytarabine sensitivity levels, indicating that molecular interactions vary with drug response. These results demonstrate that doubleS-GCV provides an efficient and reliable model selection framework for sample-specific gene network analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Statistics, Sungshin Women's University, Seoul 02844, Republic of Korea.
- School of Mathematics Statistics and Data Science, Sungshin Women's University, Seoul 01133, Republic of Korea.
- Data Science Center, Sungshin Women's University, Seoul 01133, Republic of Korea.
- M&D Data Science Center, Institute of Science Tokyo, Bunkyo-ku, Tokyo 113-8510, Japan.
- Human Genome Center, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, Tokyo 108-8639, Japan.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Oh, J., & Park, H. (2026). Sample-Specific Generalized Cross-Validation for Gene Network Analysis of Cytarabine Response in Cancer Cell Lines. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188261
Vancouver
Oh J, Park H. Sample-Specific Generalized Cross-Validation for Gene Network Analysis of Cytarabine Response in Cancer Cell Lines. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188261
BibTeX
@article{Oh2026,
author = {Oh, Jooee and Park, Heewon},
title = {Sample-Specific Generalized Cross-Validation for Gene Network Analysis of Cytarabine Response in Cancer Cell Lines},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27188261}
}
EUVIMED